查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1964076

微生物菌群定序服務市場－全球產業規模、佔有率、趨勢、機會、預測：按技術、應用、地區和競爭格局分類，2021-2031年

Microbiome Sequencing Service Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球微生物定序服務市場預計將從 2025 年的 3.2612 億美元成長到 2031 年的 4.4231 億美元，複合年成長率為 5.21%。

這些服務透過對微生物群落進行基因組分析來表徵微生物，並將其應用於各種工業和臨床用途，其主要驅動力是先進定序技術成本的顯著降低以及對依賴微生物數據的精準醫療日益成長的需求。為了支持推動這一需求的活躍研究活動，歐洲神經胃腸動力學會於2024年報告稱，過去十年中與腸道微生物組相關的論文數量已達到53,450篇，凸顯了商業性定序需求的強勁成長勢頭。

市場概覽
預測期 2027-2031
市場規模：2025年 3.2612億美元
市場規模：2031年 4.4231億美元
複合年成長率：2026-2031年 5.21%
成長最快的細分市場 合成定序
最大的市場 北美洲

阻礙市場成長的主要障礙是實驗流程和數據分析缺乏標準化通訊協定。 DNA提取和解讀方法的不統一導致研究結果不一致，使得基於微生物組的診斷方法難以檢驗結果並獲得監管部門核准。這些差異使科學格局複雜化，並阻礙了微生物定序服務廣泛接受和應用所需的統一標準的建立。

市場促進因素

高通量總體基因體學技術的進步正在從根本上改變全球市場，它提高了數據生成能力，並降低了准入門檻。超高通量定序平台的引入極大地加速了微生物DNA的處理，使得以往成本高昂的大規模群體研究在經濟上變得可行。數據生產能力的激增正在推動服務業的成長，因為實驗室正在升級基礎設施，以提供高效的深度元基因組分析。例如，Illumina在其2025年6月發布的《2024年企業社會責任報告》中指出，該公司在2024年全年利用其平台每分鐘測序10個人類基因組，這表明現代基因組分析的強大處理能力為服務提供商提供了以具有競爭力的價格提供更深入見解的基礎。

第二個主要驅動力是基於微生物組的藥物發現和治療方法的擴展。這需要專門的定序來檢驗生物醫學產品。隨著製藥公司從相關性研究轉向基於因果關係的藥物發現，對符合菌株安全性和鑑定監管標準的精準定序的需求日益成長。這一趨勢得到了大量投資的支持，例如32 Biosciences在2025年6月成功完成600萬美元的資金籌措，以加速其腸道微生物組平台的開發（根據《微生物組時報》報道）。此外，諸如MaaT Pharma和Clinigen在2025年7月達成的獨家合作協議等策略合作，旨在簡化微生物組療法的市場進入，也凸顯了該行業對高品質基因組數據的依賴。

市場挑戰

實驗室操作流程和數據分析缺乏標準化通訊協定，是全球微生物組定序服務市場發展的一大障礙。生物資訊流程和DNA萃取技術的差異常常導致數據輸出不一致，使得不同機構和研究的結果難以比較。這種可重複性不足是監管機構檢驗的主要障礙，因為監管機構需要可靠且一致的數據才能核准新的診斷和治療方法。因此，對數據品質的擔憂正在阻礙投資，延緩微生物組研究成果向可上市臨床產品的轉化，並減少商業性定序合約的數量。

近期行業數據進一步凸顯了數據效用方面的挑戰。根據皮斯托亞聯盟 (Pistoia Alliance) 2024 年的報告，48% 的生命科學專業人士認為元資料缺乏標準化是有效利用實驗數據的主要障礙。這項統計數據表明，數據處理中的不一致仍然是一個普遍存在的問題，降低了定序結果的價值。除非這些標準化方面的差距得到彌合，否則市場將難以提供可靠且可操作的洞察，而這些洞察對於推動整個產業的廣泛應用至關重要。

市場趨勢

將人工智慧 (AI) 和機器學習 (ML) 結合進行複雜資料解讀，正成為管理多維微生物資料集複雜性的關鍵趨勢。隨著元基因組資料量的激增，傳統的生物資訊工具往往難以檢測宿主表現型與微生物分類群之間的非線性關係，促使業界採用先進的計算模型進行更深入的功能分析。這些人工智慧驅動的框架對於將原始基因組數據轉化為臨床可用的生物標記至關重要，從而提升定序服務的價值，使其超越簡單的分類。為了順應這一轉變，DNAstack 於 2025 年 2 月宣布了一項 1,750 萬美元的舉措，旨在擴展其軟體，加速人工智慧驅動的基因組學和醫療保健領域的發現。這標誌著 DNAstack 向運算基礎設施的策略性轉型，以最大限度地發揮微生物組數據的潛力。

同時，面向消費者的直接微生物組檢測和個人化營養的興起，正將市場拓展到傳統臨床和學術領域之外。大眾對腸道健康的日益關注，推動了定序的健康產品的商業化，供應商透過解讀微生物譜，提供切實可行的飲食和生活方式建議。這一趨勢正將收入來源轉向大規模消費者樣本，這需要與小規模調查計劃截然不同的可擴展處理流程。為了支持這一成長，Microba Life Sciences 在 2025 年 8 月的中期報告中指出，其營收成長了 29.6%，達到 1,560 萬美元。這一成長顯然與公司旗艦檢測產品的普及密切相關，證明了個人化微生物組洞察的商業性可行性。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球微生物定序服務市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依技術（合成定定序、連接定定序、桑格法等）
    • 按應用領域（自體免疫疾病、癌症、消化系統疾病等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美微生物定序服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲微生物群定序服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區微生物定序服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲微生物群定序服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美微生物定序服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球微生物定序服務市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Microbiome Insights
  • BaseClear BV
  • Clinical Microbiomics A/S
  • Merieux NutriSciences Corporation
  • MR DNA（Molecular Research LP）
  • Prescient Medicine Holdings, Inc.
  • Rancho Biosciences LLC
  • Second Genome Inc.
  • Zymo Research Corporation
  • uBiome, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24555

The Global Microbiome Sequencing Service Market is projected to expand from USD 326.12 Million in 2025 to USD 442.31 Million by 2031, registering a CAGR of 5.21%. These services involve the genomic analysis of microbial communities to characterize microorganisms for various industrial and clinical purposes, driven largely by significant cost reductions in advanced sequencing technologies and the increasing demand for precision medicine dependent on microbial data. Underscoring the intense research activity fueling this demand, the European Society of Neurogastroenterology and Motility reported in 2024 that the number of publications regarding the gut microbiome had reached 53,450 over the previous decade, highlighting the strong momentum behind commercial sequencing requirements.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 326.12 Million
Market Size 2031USD 442.31 Million
CAGR 2026-20315.21%
Fastest Growing SegmentSequencing by synthesis
Largest MarketNorth America

A primary obstacle hindering market growth is the lack of standardized protocols for laboratory procedures and data analysis. Inconsistent methods for DNA extraction and interpretation lead to discrepancies across studies, creating difficulties in validating results and obtaining regulatory approval for diagnostics derived from microbiome data. These variations complicate the scientific landscape, making it harder to establish unified benchmarks necessary for the broader acceptance and application of microbiome sequencing services.

Market Driver

Technological advancements in high-throughput metagenomics are fundamentally transforming the global market by boosting data generation capabilities and reducing barriers to entry. The deployment of ultra-high-throughput sequencing platforms has significantly accelerated the processing of microbial DNA, making large-scale population studies economically viable where they were once cost-prohibitive. This surge in data production capacity is driving growth in the service sector as laboratories update their infrastructure to provide deep metagenomic analysis efficiently. For instance, in its June 2025 '2024 Corporate Social Responsibility Report', Illumina noted that 10 human genomes were sequenced every minute on their platforms throughout 2024, demonstrating the massive scale of modern genomic throughput that enables providers to deliver deeper insights at competitive prices.

A second major catalyst is the expansion of microbiome-based drug discovery and therapeutics, which necessitates specialized sequencing to validate live biotherapeutic products. As pharmaceutical companies shift focus from correlative studies to causative drug development, the demand for precision sequencing to meet regulatory standards for strain safety and identification has intensified. This trend is supported by significant investment, such as the $6 million funding secured by 32 Biosciences in June 2025 to advance its gut microbiome platform, as reported by Microbiome Times. Furthermore, strategic collaborations like the July 2025 exclusive agreement between MaaT Pharma and Clinigen to streamline market access for microbiome therapies further confirm the industrial reliance on high-quality genomic data.

Market Challenge

The absence of standardized protocols for laboratory procedures and data analysis serves as a critical barrier to the Global Microbiome Sequencing Service Market. Differences in bioinformatics pipelines and DNA extraction techniques frequently result in inconsistent data outputs, creating challenges when comparing results across various institutions or studies. This lack of reproducibility imposes significant hurdles for regulatory validation, as agencies mandate robust and consistent data to approve new diagnostics and therapeutics. Consequently, concerns regarding data quality discourage investment and delay the transformation of microbiome research into marketable clinical products, thereby dampening the volume of commercial sequencing contracts.

This challenge is further illustrated by recent industry data concerning data utility. In 2024, the Pistoia Alliance reported that 48% of life science professionals cited the lack of metadata standardization as a primary obstacle to effectively utilizing experimental data. This statistic underscores that inconsistencies in data handling remain a widespread issue that diminishes the value of sequencing results. As long as these standardization gaps persist, the market will struggle to provide the reliable, actionable insights required to foster widespread industrial adoption.

Market Trends

The integration of Artificial Intelligence and Machine Learning for complex data interpretation is becoming a key trend to manage the intricacies of multi-dimensional microbial datasets. As the volume of metagenomic data increases, traditional bioinformatics tools often fail to detect non-linear relationships between host phenotypes and microbial taxa, driving the industry to adopt advanced computational models for deeper functional analysis. These AI-driven frameworks are crucial for translating raw genomic data into clinically useful biomarkers, enhancing the value of sequencing services beyond basic classification. Reflecting this shift, DNAstack announced a $17.5 million initiative in February 2025 to expand software for AI-powered discoveries in genomics and healthcare, highlighting the sector's strategic move toward computational infrastructure to maximize the potential of microbiome data.

Concurrently, the rise of Direct-to-Consumer microbiome testing and personalized nutrition is extending the market's reach beyond traditional clinical and academic spheres. Growing public interest in gut health is fueling the commercialization of sequencing-based wellness products, where providers interpret microbial profiles to offer actionable dietary and lifestyle advice. This trend shifts revenue streams toward high-volume consumer samples, requiring scalable processing pipelines distinct from low-volume research projects. Evidencing this growth, Microba Life Sciences reported a 29.6% revenue increase to $15.6 million in their August 2025 preliminary report, a rise explicitly linked to the growing adoption of their core testing products, validating the commercial viability of personalized microbiome insights.

Key Market Players

  • Microbiome Insights
  • BaseClear BV
  • Clinical Microbiomics A/S
  • Merieux NutriSciences Corporation
  • MR DNA (Molecular Research LP)
  • Prescient Medicine Holdings, Inc.
  • Rancho Biosciences LLC
  • Second Genome Inc.
  • Zymo Research Corporation
  • uBiome, Inc.

Report Scope

In this report, the Global Microbiome Sequencing Service Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microbiome Sequencing Service Market, By Technology

  • Sequencing by synthesis
  • Sequencing by ligation
  • Sanger sequencing
  • Others

Microbiome Sequencing Service Market, By Application

  • Autoimmune Disorder
  • Cancer
  • Gastrointestinal Disorders
  • Others

Microbiome Sequencing Service Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microbiome Sequencing Service Market.

Available Customizations:

Global Microbiome Sequencing Service Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microbiome Sequencing Service Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Sequencing by synthesis, Sequencing by ligation, Sanger sequencing, Others)
    • 5.2.2. By Application (Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Microbiome Sequencing Service Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Microbiome Sequencing Service Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Microbiome Sequencing Service Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Microbiome Sequencing Service Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Application

7. Europe Microbiome Sequencing Service Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Microbiome Sequencing Service Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Application
    • 7.3.2. France Microbiome Sequencing Service Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Microbiome Sequencing Service Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Microbiome Sequencing Service Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Microbiome Sequencing Service Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Application

8. Asia Pacific Microbiome Sequencing Service Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Microbiome Sequencing Service Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Application
    • 8.3.2. India Microbiome Sequencing Service Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Microbiome Sequencing Service Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Microbiome Sequencing Service Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Microbiome Sequencing Service Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Application

9. Middle East & Africa Microbiome Sequencing Service Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Microbiome Sequencing Service Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Microbiome Sequencing Service Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Microbiome Sequencing Service Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Application

10. South America Microbiome Sequencing Service Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Microbiome Sequencing Service Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Microbiome Sequencing Service Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Microbiome Sequencing Service Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Microbiome Sequencing Service Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Microbiome Insights
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. BaseClear BV
  • 15.3. Clinical Microbiomics A/S
  • 15.4. Merieux NutriSciences Corporation
  • 15.5. MR DNA (Molecular Research LP)
  • 15.6. Prescient Medicine Holdings, Inc.
  • 15.7. Rancho Biosciences LLC
  • 15.8. Second Genome Inc.
  • 15.9. Zymo Research Corporation
  • 15.10. uBiome, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer